Castleark Management LLC Edwards Lifesciences Corp Transaction History

Castleark Management LLC

$2.41 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$68.3 - $87.44 $16.4 Million - $21 Million	-239,900 Reduced 56.92%	181,595 $13.5 Million
Q3 2022 Nov 15, 2022	BUY	$82.37 - $107.29 $702,616 - $915,183	8,530 Added 2.07%	421,495 $34.8 Million
Q2 2022 Aug 16, 2022	BUY	$86.5 - $128.27 $3.99 Million - $5.92 Million	46,150 Added 12.58%	412,965 $39.3 Million
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $2.01 Million - $2.53 Million	-19,680 Reduced 5.09%	366,815 $43.2 Million
Q4 2021 Feb 16, 2022	SELL	$106.37 - $130.68 $89,350 - $109,771	-840 Reduced 0.22%	386,495 $50.1 Million
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $5.35 Million - $6.38 Million	-51,950 Reduced 11.83%	387,335 $43.9 Million
Q2 2021 Aug 17, 2021	BUY	$83.84 - $104.76 $17.2 Million - $21.5 Million	205,240 Added 87.69%	439,285 $45.5 Million
Q1 2021 May 14, 2021	BUY	$78.68 - $90.67 $955,962 - $1.1 Million	12,150 Added 5.48%	234,045 $19.6 Million
Q4 2020 Feb 17, 2021	SELL	$71.69 - $91.23 $432,649 - $550,573	-6,035 Reduced 2.65%	221,895 $20.2 Million
Q3 2020 Nov 16, 2020	BUY	$67.19 - $87.44 $1.85 Million - $2.41 Million	27,520 Added 13.73%	227,930 $18.2 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $11.3 Million - $15.2 Million	197,240 Added 6222.08%	200,410 $13.9 Million
Q1 2020 May 13, 2020	BUY	$52.41 - $81.0 $90,669 - $140,130	1,730 Added 120.14%	3,170 $598,000
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $77,436 - $88,657	-1,080 Reduced 42.86%	1,440 $336,000
Q2 2019 Aug 13, 2019	SELL	$55.74 - $64.41 $81,937 - $94,682	-1,470 Reduced 36.84%	2,520 $466,000
Q4 2018 Feb 12, 2019	SELL	$46.41 - $56.94 $3.54 Million - $4.34 Million	-76,260 Reduced 95.03%	3,990 $611,000
Q3 2018 Nov 15, 2018	SELL	$45.7 - $58.03 $4.44 Million - $5.64 Million	-97,147 Reduced 54.76%	80,250 $14 Million
Q2 2018 Aug 15, 2018	BUY	$42.45 - $51.3 $7.4 Million - $8.94 Million	174,207 Added 5461.03%	177,397 $25.8 Million
Q1 2018 May 15, 2018	BUY	$37.19 - $47.45 $27,148 - $34,638	730 Added 29.67%	3,190 $445,000
Q4 2017 Feb 15, 2018	BUY	$33.79 - $39.39 $30,073 - $35,057	890 Added 56.69%	2,460 $277,000
Q3 2017 Nov 15, 2017	BUY	$36.29 - $38.83 $56,975 - $60,963	1,570	1,570 $172,000

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.24 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.45 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.14 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.78 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$916 Million
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleark Management LLC with notifications on news.

Account